Co-Authors
This is a "connection" page, showing publications co-authored by Piero Olliaro and Peter Horby.
Connection Strength
0.717
-
Evaluating clinical characteristics studies produced early in the Covid-19 pandemic: A systematic review. PLoS One. 2021; 16(5):e0251250.
Score: 0.236
-
Regulatory and Operational Complexities of Conducting a Clinical Treatment Trial During an Ebola Virus Disease Epidemic. Clin Infect Dis. 2018 04 17; 66(9):1454-1457.
Score: 0.191
-
Incidence and risk factors for persistent symptoms in adults previously hospitalized for COVID-19. Clin Exp Allergy. 2021 09; 51(9):1107-1120.
Score: 0.060
-
Chemoprophylaxis trial designs in epidemics: insights from a systematic review of COVID-19 study registrations. Trials. 2021 May 29; 22(1):370.
Score: 0.059
-
Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study. Lancet Respir Med. 2021 04; 9(4):349-359.
Score: 0.058
-
Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score. BMJ. 2020 09 09; 370:m3339.
Score: 0.056
-
Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study. BMJ. 2020 08 27; 370:m3249.
Score: 0.056